Department of Cardiac Surgery, Central Clinic Bad Berka, Robert-Koch Allee 9, 99437 Bad Berka, Germany.
J Invasive Cardiol. 2020 Sep;32(9):330-334. doi: 10.25270/jic/20.00050. Epub 2020 May 20.
New transcatheter equipment and accumulated experience have stimulated further refinements in implantation techniques. We aimed to compare the outcomes of transfemoral transcatheter aortic valve replacement (TF-TAVR) with and without the use of contrast medium (CM) in patients with glomerular filtration rate (GFR) <30 mL/min/1.73 m².
This single-center, retrospective study included all patients who underwent TF-TAVR procedure with Edwards Sapien balloon-expandable bioprostheses between September 2017 and September 2018 at the Zentralklinik Bad Berka Germany, and compared outcomes of TF-TAVR with and without the use of CM.
A total of 98 consecutive patients were included in this study; 25 patients underwent TF-TAVR without the use of CM and 73 patients underwent TF-TAVR with the use of CM. Acute kidney injury was significantly higher in patients who received CM (15 patients [20.5%] in the control group vs 1 patient [4%] in the study group; P=.04). Other procedure-related complications were equally distributed between both groups.
TF-TAVR without the use of CM can be considered a safe and reproducible alternative technique. Furthermore, it reduced the incidence of postoperative acute kidney injury in patients with GFR <30 mL/min/1.73 m².
新的经导管设备和积累的经验刺激了植入技术的进一步改进。我们旨在比较在肾小球滤过率(GFR)<30 mL/min/1.73 m²的患者中使用和不使用对比剂(CM)的经股动脉经导管主动脉瓣置换术(TF-TAVR)的结果。
这是一项单中心、回顾性研究,纳入了 2017 年 9 月至 2018 年 9 月期间在德国巴特贝雷克中心医院接受爱德华兹·萨皮恩球囊扩张生物瓣 TF-TAVR 手术的所有患者,并比较了使用和不使用 CM 的 TF-TAVR 结果。
本研究共纳入 98 例连续患者;25 例患者未使用 CM 行 TF-TAVR,73 例患者使用 CM 行 TF-TAVR。接受 CM 的患者急性肾损伤发生率明显更高(对照组 15 例[20.5%],研究组 1 例[4%];P=.04)。两组之间其他与手术相关的并发症发生率相当。
不使用 CM 的 TF-TAVR 可以被认为是一种安全且可重复的替代技术。此外,它降低了 GFR<30 mL/min/1.73 m²的患者术后急性肾损伤的发生率。